Arrhythmias & electrophysiology

PROlonged posterior PERicardial chest tube treatment to reduce rates of postoperative atrial fibrillation following cardiac surgery (PROPER trial): Rationale and design of a prospective, multinational, randomized clinical trial

Am Heart JPublished prospective, multinational, randomized, controlled clinical trial

Study context

Population
Patients undergoing non-emergent, first-time coronary bypass grafting, aortic valve replacement, aortic surgery without circulatory arrest, or a combination of these proceduresplanned enrolment
Participants
624 patients
Planned comparison
Prolonged drainage using a posterior pericardial chest tube vs standard care
Primary endpoint
Atrial fibrillation (AF) recorded within seven days after surgery
Follow-up
Within seven days after surgery
Methodological detailseight Nordic cardiac surgery centers, wearable electrocardiographic patch monitor in addition to routine surveillance, rationale and design (no results reported)
  • Eight Nordic cardiac surgery centers
  • Wearable electrocardiographic patch monitor in addition to routine surveillance
  • Rationale and design (no results reported)

No results yet. This paper sets out the design of a trial; its results are to come.

Further findings

Secondary endpoints: Atrial fibrillation (AF) recurrence, hospitalization due to bleeding or ischemic stroke, and all-cause mortality · five years of follow-up

Patients will be followed for five years.

Original publication

PROlonged posterior PERicardial chest tube treatment to reduce rates of postoperative atrial fibrillation following cardiac surgery (PROPER trial): Rationale and design of a prospective, multinational, randomized clinical trial. Am Heart J. Published 28 October 2026. doi:10.1016/j.ahj.2026.107635

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.